NeueHealth Inc（NEUE）资讯与事件NEUENeueHealth Inc

NeueHealth reports Q2 EPS ($2.62) vs. ($8.65) last year

Reports Q2 revenue $209.08M vs. $225.99M last year. "We are pleased to report another strong quarter of financial results as we continue to build on the momentum we have established across our business this year," said Mike Mikan, President and CEO of NeueHealth. "We delivered our sixth consecutive quarter of Adjusted EBITDA profitability, and we are continuing to see strong performance across product categories, including the ACA Marketplace, Medicare, and Medicaid. In the second quarter and beyond, we are focused on advancing our end-to-end, value-based care enablement platform that will power the future of our company, supporting clinical, financial, and administrative functions to create a more aligned and coordinated care experience for all."

NeueHealth reports Q4 EPS ($1.94) vs. ($30.47) last year

Reports Q4 revenue $232.64M vs. $292.87M last year. "In 2024, we delivered our strongest financial performance to date, demonstrating the power of our value-driven, consumer-centric care model," said CEO Mike Mikan. "We have established a strong foundation to drive strategic growth in 2025 with a focus on serving more consumers in new and existing markets and building on the relationships we have formed with payors and providers across the industry. I am excited for the future of our company and believe we are well-positioned to continue to bring a seamless, more coordinated care experience to all in 2025 and beyond."

NeueHealth rises 70.1%

NeueHealth is up 70.1%, or $3.02 to $7.33.